Psoriatic arthritis affects up to 40% of people who are living with psoriasis and can often go undiagnosed, particularly in its milder form. Diagnosing it can be even more tricky because its symptoms frequently mimic those of other forms of inflammatory arthritis, such as rheumatoid arthritis and gout. Although substantial progress has been achieved in understanding the pathogenesis, outcome and treatment of PsA, there is still an unmet need to better characterize PsA.
In recognition of the need to advance knowledge on the pathophysiology of psoriatic arthritis, five European research institutions have come together to launch the 2nd PARTNER Psoriatic Arthritis Network Fellowship Program.
Learn more about PARTNER, the research institutions and the applications here: www.partner-fellows.eu
Prof. Dennis McGonagle, University of Leeds
Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM)